Psychedelic Invest is excited to announce that we’ve added 7 new companies to the Psychedelic Invest Index – making us fully up to date on all recent listings. The Psychedelic Invest Index, the first-ever to track the entire public sector of the psychedelic market, now features: Tryp Therapeutics Inc (TRYP)BetterLife Pharma Inc. (BETR)Mindset Pharma Inc. (MSET)Entheon … [Read more...] about January, 2021 Update: Psychedelic Index Adds 7 New Companies
Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.
“The standard of care in mental health is broken and has been for decades.” We were speaking with Yaron Conforti, the CEO and Director of Novamind about the catalyst that led to the creation of the company which is going public today, January 5th 2021. Yaron explained that mental health has been in crisis mode for decades. And that’s before COVID hit. Post-COVID, it’s … [Read more...] about Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind
After gaining 54.66% in the month of November, the Psychedelic Invest Index had a much quieter month in December, finishing with a gain of only 2.23%. On Thursday, December 31, 2020, the index closed at a price of $86.69 and marked the end of what was a historic year for the entire psychedelic sector. Since launching in June of 2020, the Psychedelic Invest Index has … [Read more...] about Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge
Tryp Therapeutics, a development-stage pharmaceutical company focused on psilocybin and other treatments, will begin trading on the Canadian Stock Exchange (CSE) today under the symbol “TRYP”. After initially attempting to sell 17.4 million units at $0.25 to investors, the company said Monday it would fully exercise its over-allotment option, increasing the total number of … [Read more...] about Tryp Therapeutics Goes Public; Here’s Everything You Need to Know
A firm touting itself as “Britain's first psychedelic healthcare fund” has launched with the intention to invest more than £10 million ($13.5 million) in psychedelic focused companies. Neo Kuma Ventures will fund what it believes are "the most exciting, high quality and scientifically sound players in the industry." The fund has previously invested in atai Life … [Read more...] about A New Fund Dedicated to Psychedelic Investments Has Launched in the UK